Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Brain Injuries, Traumatic (Phase 1)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 1)
Endometrial Neoplasms (Phase 2)
Fatty Liver (Early Phase 1)
Genital Neoplasms, Female (Phase 2)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Healthy Volunteers (Phase 1)
Human Papillomavirus Viruses (Phase 1)
Kidney Neoplasms (Phase 2)
Lymphoma (Phase 1)
Meningioma (Phase 1)
Metabolism (Early Phase 1)
Mutation (Phase 1)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 1/Phase 2)
Neuroendocrine Tumors (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Cyst (Phase 1)
Pancreatic Neoplasms (Phase 2)
Papilloma (Phase 1)
Prostatic Neoplasms (Phase 2)
Sarcoma (Early Phase 1)
Subarachnoid Hemorrhage (Phase 1)
Thyroid Neoplasms (Early Phase 1)
Uterine Cervical Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue